Liver Cancer Program: For Patients

Patient ChartsAll patients with primary liver cancer referred to the National Cancer Institute are presented and discussed at a weekly interdisciplinary tumor board to identify the best and most effective treatment options.

About Our Trials

To see a complete list of clinical trials for patients with liver cancer, visit: Find a Clinical Trial

The NCI Liver Cancer Program features a variety of clinical trials, including a national collaborative network natural history study, NCI CLARITY.

Clinical Team

Patient Referrals

Donna Mabry Hrones

Donna Mabry Hrones
Nurse Practitioner
Thoracic and Gastrointestinal Oncology Branch
NCI Center for Cancer Research
Tel: 240-858-3155

Second Opinion and Consultations

If you have recently been diagnosed or have been diagnosed in the past with an HCC or cholangiocellular carcinoma and would like to hear a second opinion, please contact Dr. Greten by e-mail.

Tim F. Greten, M.D.
Senior Investigator (link sends e-mail)
Cecilia Monge, M.D.
Assistant Research Physician
Elizabeth Akoth
Research Nurse 
Santhana Webb
Research Nurse
Angelicia Garrison
Angelicia Garrison
Patient Care Coordinator

About Liver Cancer

The liver has many important functions in the body. For example, it cleans toxins from the blood, makes bile that helps digest fat, makes substances that help blood clot, and makes, stores, and releases sugar for energy.

Primary liver cancer is cancer that starts in the liver. The most common type of primary liver cancer is hepatocellular carcinoma, which occurs in the tissue of the liver. When cancer starts in other parts of the body and spreads to the liver, it is called liver metastasis.

Liver cancer is rare in children and teenagers, but there are two types of liver cancer that can form in children. Hepatoblastoma occurs in younger children, and hepatocellular carcinoma occurs in older children and teenagers.

The bile ducts are tubes that carry bile between the liver and gallbladder and the intestine. Bile duct cancer is also called cholangiocarcinoma. When it begins in the bile ducts inside the liver, it is called intrahepatic cholangiocarcinoma. When it begins in the bile ducts outside the liver, it is called extrahepatic cholangiocarcinoma. Extrahepatic cholangiocarcinoma is much more common than intrahepatic cholangiocarcinoma.

Educational Resources for Patients

Learn more by visiting the NCI links below.